lisa 2 mg/0,03 mg
laboratorios leon farma, s.a. - spania - combinatii (dienogestum+etinilestradiolum) - compr. film. - 2mg/0,03mg - contraceptive hormonale pentru uz sistemic progesteroni si estrogeni combinatii fixe
dupixent
sanofi winthrop industrie - dupilumab - dermatitis, atopic; prurigo; esophageal diseases; asthma; sinusitis - agenți pentru dermatită, cu excepția corticosteroizilor - atopic dermatitisadults and adolescentsdupixent is indicated for the treatment of moderate-to-severe atopic dermatitis in adults and adolescents 12 years and older who are candidates for systemic therapy. children 6 months to 11 years of agedupixent is indicated for the treatment of severe atopic dermatitis in children 6 months to 11 years old who are candidates for systemic therapy. asthmaadults and adolescentsdupixent is indicated in adults and adolescents 12 years and older as add-on maintenance treatment for severe asthma with type 2 inflammation characterised by raised blood eosinophils and/or raised fraction of exhaled nitric oxide (feno), see section 5. 1, who are inadequately controlled with high dose inhaled corticosteroids (ics) plus another medicinal product for maintenance treatment. children 6 to 11 years of agedupixent is indicated in children 6 to 11 years old as add-on maintenance treatment for severe asthma with type 2 inflammation characterised by raised blood eosinophils and/or raised fraction of exhaled nitric oxide (feno), who are inadequately controlled with medium to high dose inhaled corticosteroids (ics) plus another medicinal product for maintenance treatment. chronic rhinosinusitis with nasal polyposis (crswnp)dupixent is indicated as an add-on therapy with intranasal corticosteroids for the treatment of adults with severe crswnp for whom therapy with systemic corticosteroids and/or surgery do not provide adequate disease control. prurigo nodularis (pn)dupixent is indicated for the treatment of adults with moderate-to-severe prurigo nodularis (pn) who are candidates for systemic therapy. eosinophilic esophagitis (eoe)dupixent is indicated for the treatment of eosinophilic esophagitis in adults and adolescents 12 years and older, weighing at least 40 kg, who are inadequately controlled by, are intolerant to, or who are not candidates for conventional medicinal therapy.
sandimmun neoral 100 mg capsule moi
novartis pharma ag - cyclosporinum - capsule moi - 100 mg
sandimmun neoral 25 mg capsule moi
novartis pharma ag - cyclosporinum - capsule moi - 25 mg
sandimmun neoral 50 mg capsule moi
novartis pharma ag - cyclosporinum - capsule moi - 50 mg
deferasirox msn laboratories 90 mg
pharmadox healthcare ltd. - malta - deferasiroxum - compr. film. - 90mg - alte preparate terapeutice chelatori de fer
staquis
pfizer europe ma eeig - crisaborole - dermatita, atopică - alte preparate dermatologice - staquis este indicat pentru tratamentul formelor ușoare și moderate de dermatita atopica la adulți, adolescenți și copii cu vârsta de 2 ani cu ≤ 40% suprafața corporală (bsa) afectate.
deferasirox msn laboratories 180 mg
pharmadox healthcare ltd. - malta - deferasiroxum - compr. film. - 180mg - alte preparate terapeutice chelatori de fer
deferasirox msn laboratories 360 mg
pharmadox healthcare ltd. - malta - deferasiroxum - compr. film. - 360mg - alte preparate terapeutice chelatori de fer
levocet ods 5 5 mg film orodispersabil
zim laboratories limited - levocetirizinum - film orodispersabil - 5 mg